These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21287714)

  • 1. Short-term and long-term outcomes of autoimmune pancreatitis.
    Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Igarashi Y
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):146-52. PubMed ID: 21287714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study.
    Kamisawa T; Yoshiike M; Egawa N; Nakajima H; Tsuruta K; Okamoto A
    Pancreatology; 2005; 5(2-3):234-8; discussion 238-40. PubMed ID: 15855821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
    Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome.
    Kamisawa T; Okamoto A; Wakabayashi T; Watanabe H; Sawabu N
    Scand J Gastroenterol; 2008; 43(5):609-13. PubMed ID: 18415756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of autoimmune pancreatitis.
    Kamisawa T; Okamoto A
    J Gastroenterol; 2007 May; 42 Suppl 18():59-62. PubMed ID: 17520225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into predictors of autoimmune pancreatitis relapse after steroid therapy.
    Ujita W; Kamisawa T; Chiba K; Nakahodo J; Tabata H; Setoguchi K; Igarashi Y; Matsuda T
    Scand J Gastroenterol; 2024 Oct; 59(10):1202-1208. PubMed ID: 39257347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
    Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
    Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis.
    Song TJ; Kim JH; Kim MH; Jang JW; Park DH; Lee SS; Seo DW; Lee SK; Yu E
    J Gastroenterol Hepatol; 2012 Apr; 27(4):700-8. PubMed ID: 21929653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy.
    Kamisawa T; Egawa N; Inokuma S; Tsuruta K; Okamoto A; Kamata N; Nakamura T; Matsukawa M
    Pancreas; 2003 Oct; 27(3):235-8. PubMed ID: 14508128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metachronous extrapancreatic lesions in autoimmune pancreatitis.
    Takuma K; Kamisawa T; Anjiki H; Egawa N; Igarashi Y
    Intern Med; 2010; 49(6):529-33. PubMed ID: 20228586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids.
    Ohno Y; Kumagi T; Yokota T; Azemoto N; Tanaka Y; Tange K; Inada N; Miyata H; Imamura Y; Koizumi M; Kuroda T; Hiasa Y;
    Orphanet J Rare Dis; 2016 Jul; 11(1):103. PubMed ID: 27465035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study of steroid therapy for patients with autoimmune pancreatitis in a Chinese population.
    Liu B; Li J; Yan LN; Sun HR; Liu T; Zhang ZX
    World J Gastroenterol; 2013 Jan; 19(4):569-74. PubMed ID: 23382638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy.
    Nishino T; Toki F; Oyama H; Shimizu K; Shiratori K
    Intern Med; 2006; 45(8):497-501. PubMed ID: 16702740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing autoimmune pancreatitis from pancreaticobiliary cancers: current strategy.
    Agrawal S; Daruwala C; Khurana J
    Ann Surg; 2012 Feb; 255(2):248-58. PubMed ID: 21997803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study.
    Moon SH; Kim MH; Park DH; Hwang CY; Park SJ; Lee SS; Seo DW; Lee SK
    Gut; 2008 Dec; 57(12):1704-12. PubMed ID: 18583399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune pancreatitis and IgG4-associated sclerosing cholangitis.
    Nishimori I; Otsuki M
    Best Pract Res Clin Gastroenterol; 2009; 23(1):11-23. PubMed ID: 19258183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.
    Ghazale A; Chari ST; Zhang L; Smyrk TC; Takahashi N; Levy MJ; Topazian MD; Clain JE; Pearson RK; Petersen BT; Vege SS; Lindor K; Farnell MB
    Gastroenterology; 2008 Mar; 134(3):706-15. PubMed ID: 18222442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Steroid responsive pancreatic mass-forming type 2 autoimmune pancreatitis].
    Chun YJ; Chang JH; Lee IS; Lee JE; Chung MK; Jung CK; Choi MG; Chung IS
    Korean J Gastroenterol; 2011 Jul; 58(1):53-7. PubMed ID: 21778805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis.
    Morselli-Labate AM; Pezzilli R
    J Gastroenterol Hepatol; 2009 Jan; 24(1):15-36. PubMed ID: 19067780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategy for autoimmune pancreatitis.
    Kamisawa T; Satake K
    Adv Med Sci; 2008; 53(2):145-8. PubMed ID: 18762470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.